Daniel Abran

Title: The Innovative Journey of Inventor Daniel Abran

Introduction

Daniel Abran, a notable inventor based in Vaudreuil, Canada, has made significant contributions to medical science through his inventive work. With a total of four patents to his name, he has focused on developing groundbreaking solutions to improve health outcomes.

Latest Patents

Among his latest innovations are impactful patents, including "Glucagon-like peptide-1 analogs with long duration of action." This invention describes novel GLP-1 analogs that possess enhanced biological potency and prolonged pharmacological activity. Specifically, they relate to GLP-1 analogs that are 28 or 29 amino acids long, featuring amino acid substitutions at critical positions, including 8, 20, 27, 30, and 33.

Another significant contribution is the patent for "Antagonistic peptides of prostaglandin E2 receptor subtype EP4." This invention entails peptides that serve as antagonists for the EP4 receptor, providing potential treatments for various medical conditions, including oligouric nephropathy and abnormal intestinal crypt cell proliferation. The formula for these antagonistic peptides is delineated as X-A-RY, wherein 'X' can be a hydrogen atom or an amine protecting group, leading to either carbamate or amide formation when reacting with an amine.

Career Highlights

Daniel currently works at Theratechnologies Inc., a company recognized for its innovative approach in the biotechnology sector. His expertise in peptide design and pharmacology illustrates his dedication to advancing medical therapies that can benefit patients worldwide.

Collaborations

Throughout his career, Daniel has collaborated with esteemed colleagues, including Krishna G Peri and Serge Moffett. These professional partnerships have enabled him to pursue complex projects and leverage diverse expertise to enhance the quality and efficacy of his inventions.

Conclusion

Daniel Abran's inventive contributions showcase his commitment to innovation in the medical field. His patents not only address critical health issues but also highlight the impactful role of dedicated inventors in the advancement of science and technology. Through his work at Theratechnologies Inc., he continues to push the boundaries of what is possible in medicine.